Table 2.
Trends in Comorbid Conditions among Patients with Heart Failure
Variable | 1988–1994 (n = 581) | 1999–2002 (n = 280) | 2003–2008 (n = 534) | Change, 1988–2008 (95% CI) | P Value |
---|---|---|---|---|---|
MI | 58.8 (3.3) | 46.5 (3.3) | 47.7 (3.1) | −11.2 (−20.3-−2.0) | .02 |
Angina | NAb | 38.7 (3.8) | 26.9 (2.7) | −11.9 (−12.1-−2.6)c | .01c |
Stroke | 17.6 (2.1) | 16.6 (2.6) | 19.4 (2.4) | 1.8 (−4.8–8.4) | .59 |
Diabetesa | 24.7 (2.7) | 29.3 (2.9) | 38.3 (2.3) | 13.6 (6.4–20.7) | <.001 |
Blood pressure (BP) | |||||
Hypertensiona | 67.8 (2.5) | 71.2 (3.7) | 73.3 (2.2) | 5.5 (−1.1–12.1) | .10 |
Systolic BP (mm Hg) | 141.7 (1.1) | 131.7 (1.8) | 130.6 (1.3) | −11.2 (−14.5-−7.8) | <.001 |
Diastolic BP (mm Hg) | 73.1 (1.1) | 66.9 (1.5) | 65.9 (0.7) | −7.2 (−9.9-−4.5) | <.001 |
Cholesterol | |||||
Hypercholesterolemiaa | 41.3 (3.0) | 49.3 (3.9) | 53.5 (2.8) | 12.2 (5.0–19.4) | .001 |
LDL cholesterold (mg/dL) | 139.2 (3.1) | 116.7 (5.1) | 105.3 (4.6) | −33.9 (−44.9-−22.8) | <.001 |
HDL cholesterol <40 mg/dL | 35.1 (2.9) | 34.0 (3.8) | 25.8 (2.2) | −9.2 (−16.6-−1.8) | .02 |
Obesity | |||||
Obesitya | 32.8 (2.5) | 40.3 (4.7) | 46.8 (2.5) | 13.9 (7.5–20.4) | <.001 |
BMI (kg/m2) | 28.3 (0.3) | 30.0 (0.8) | 31.1 (0.4) | 2.8 (1.8–3.7) | <.001 |
Waist circumference (cm) | |||||
Women | 95.9 (1.2) | 102.6 (1.9) | 105.5 (1.2) | 9.6 (6.1–12.1) | <.001 |
Men | 102.0 (1.0) | 105.1 (1.2) | 109.2 (1.4) | 7.2 (3.7–10.7) | <.001 |
High-risk waist circumferencea | 57.6 (3.4) | 73.0 (2.9) | 75.7 (2.7) | 18.0 (8.5–27.6) | <.001 |
Kidney function | |||||
Kidney diseasea | 34.7 (2.9) | 41.2 (3.6) | 45.9 (2.1) | 11.2 (4.2–18.3) | .002 |
Creatinine (mg/dL) | 1.10 (0.06) | 1.29 (0.09) | 1.23 (0.04) | 0.13 (0.00–0.26) | .06 |
Creatinine >2 mg/dL | 4.6 (1.8) | 6.9 (1.8) | 7.4 (1.0) | 2.8 (−1.2–6.7) | .17 |
Anemiaa | 15.3 (2.7) | 15.0 (1.8) | 22.2 (2.7) | 6.9 (−0.6–14.5) | .07 |
Asthma | 18.0 (2.5) | 16.8 (2.7) | 24.6 (1.9) | 6.6 (0.3–12.9) | .04 |
Arthritis | 60.4 (2.9) | 68.5 (3.3) | 62.0 (2.4) | 1.6 (−5.4–8.6) | .65 |
COPD | 26.2 (2.8) | 26.8 (2.9) | 30.9 (2.3) | 4.8 (−2.5–12.1) | .20 |
Cancer | 21.5 (2.5) | 29.3 (2.8) | 24.4 (2.0) | 2.9 (−3.6–9.4) | .38 |
Thyroid disease | 9.9 (1.5) | 15.2 (2.8) | 22.9 (1.9) | 13.0 (8.3–17.7) | .001 |
Osteoporosis | 4.9 (1.2) | 13.6 (3.1) | 16.4 (2.5) | 11.5 (5.9–17.1) | .001 |
BMI = body mass index; CI = confidence interval; COPD = chronic obstructive pulmonary disease; HDL = high-density lipoprotein; LDL = low-density lipoprotein; MI = myocardial infarction.
All variables are in weighted % or mean (standard error).
See “Materials and Methods” for definitions.
Data not available because data collection methods differed substantially from methods in subsequent years.
Comparison is for 1999–2002 vs 2003–2008.
Calculated for fasting subsample only (n = 271 in 1988–1994, n = 105 in 1999–2002, n = 136 in 2003–2008).